论文部分内容阅读
目的评价弥可保联合银杏达莫治疗糖尿病周围神经病变(Diabetic peripheral neuropathy,DPN)的疗效。方法 100例DPN患者,分为对照组和观察组。对照组给予弥可保治疗,观察组给予弥可保联合银杏达莫治疗。结果观察组总有效率84.00%高于对照组66.00%,差异有统计学意义(P<0.01)。观察组MNCV、SNCV改善情况优于对照组,差异有统计学意义(P<0.05)。结论弥可保联合银杏达莫治疗DPN患者疗效可靠。
Objective To evaluate the therapeutic effect of Mi-Pak combined with ginkgo-damo on diabetic peripheral neuropathy (DPN). Methods 100 cases of DPN patients were divided into control group and observation group. The control group was given Mi Kebao treatment, the observation group was given Mi Kebao ginkgo biloba treatment. Results The total effective rate in observation group was 84.00%, which was higher than that in control group (66.00%), the difference was statistically significant (P <0.01). The observation group MNCV, SNCV better than the control group, the difference was statistically significant (P <0.05). Conclusion Miqibao combined with ginkgo dipyridamole treatment of DPN patients with reliable results.